Crescendo Bioscience Announces Results from a Meta-Analysis of Studies with Vectra® DA at the 2017 Annual European Congress of Rheumatology
Company to Seek FDA Approval of BRACAnalysis CDx Test in HER2- Metastatic Breast Cancer